ESCMID Study Group for Antimicrobial Resistance Surveillance - ESGARS
News & Activities
- Sunday, 28 April 2013
13.15 - 14.15 (Hall 9)
ESGARS Business Meeting: All interested persons are cordially invited to join the meeting and plan future ESGARS activities.
16.00 - 18.00 (Hall D)
ESGARS Symposium: Resistance to non-beta-lactam antibiotics in Gram-negative bacilli
For more details, please check the ECCMID programme.
- 31 March, 16.30-18.30
2-hour Symposium "Surveillance of resistance in Europe"
Arranged with ESGARS and the European Committee on Antimicrobial Susceptibility Testing (EUCAST). - 1 April, 9.00-11.00
2-hour Symposium "Resistance to anti-Gram-positive agents in Europe" - 2 April, 16.00-18.00
2-hour Symposium "Non-MBL carbapenemases in Gram-negative bacilli" - 2 April, 13.00-14.00 (Meeting Room 10)
ESGARS Business Meeting
All interested persons are cordially invited to join the meeting and plan future ESGARS activities.
For more details, please check the ECCMID programme.
Quinolones: from Bench to Bedside
ESGARS organised this ESCMID PGEC in Santander, Spain, 5 - 7 October 2011.
- 7 May, 8.45-10.45
Educational Workshop EW08 "Anti-TB drug resistance" - 7 May, 13.30-15.30
Symposium "Surveillance of resistance in M. tuberculosis and potential impact of epidemiological cut-off values" - 9 May, 9.00-10.00 (Room Yellow 3)
ESGARS Business Meeting
All interested persons are cordially invited to join the meeting and plan future ESGARS activities.
For more details, please check the ECCMID/ICC programme.
Research Project
Retrieval of antimicrobial susceptibility data from invasive infections, urinary tract infections and lower respiratory tract infections - a pilot project involving Turkey and Israel. The project has received funding by ESCMID (EUR 30'000) and the aim for 2011 is to establish an interactive database.
Project lead: Christian Giske
Giske CG, Cornaglia G; on behalf of the ESCMID Study Group on Antimicrobial Resistance Surveillance (ESGARS)
Drug Resist Updat. 2010 Aug-Oct;13(4-5):93-8
Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic - the EUCAST and ESGARS Perspective
ESGARS organised this ESCMID PGEC in collaboration with EUCAST in Madrid, Spain, 27 - 30 September 2010.
Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, Malamou-Lada E, Martinez-Martinez L, Navarro F, Nordmann P, Peixe L, Pournaras S, Rossolini GM, Tsakris A, Vatopoulos A, Cantón R.
Clin Microbiol Infect. 2010 Feb;16(2):112-22
Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, Rossolini GM, Souli M, Giamarellou H.
Clin Microbiol Infect. 2010 Feb;16(2):102-11
CMI Theme Section
The emerging threat of acquired carbapenemases in Gram-negative bacteria
Inspired by and based on an ESGARS experts meeting on carbapenemases held in Athens, Greece, December 2008.
CMI contents are freely available for ESCMID members. Please log in or register.
